Mayo Clinic Proceedings found that patients with type 2 diabetes who were treated with dasatinib for a year experienced greater reductions in A1C and body weight than those treated with imatinib. Patients who were treated with dasatinib also required less total daily insulin."/> Mayo Clinic Proceedings found that patients with type 2 diabetes who were treated with dasatinib for a year experienced greater reductions in A1C and body weight than those treated with imatinib. Patients who were treated with dasatinib also required less total daily insulin."/> Greater benefits found for dasatinib than imatinib

Greater benefits found for dasatinib than imatinib

2021-11-29

A study in Mayo Clinic Proceedings found that patients with type 2 diabetes who were treated with dasatinib for a year experienced greater reductions in A1C and body weight than those treated with imatinib. Patients who were treated with dasatinib also required less total daily insulin.

Full story:

DiabetesPro SmartBrief

Diabetes Treatment News

Designed specifically for health care professionals, DiabetesPro SmartBrief is a FREE, daily e-mail newsletter. It provides the latest news, trends, and technology updates that matter most to health care professionals.